In some studies, the gap between VEGF and receptors is necessary for developing OHSS, and the VEGF-R2 inhibitor, like the dopamine agonist, can reverse hCG action on vascular permeability, and can also act to prevent and treat OHSS (3, 33, 34). Here, KDR is linked to ovarian hyperstimulation syndrome.